Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Surgical Spirit IP is a topical antiseptic solution manufactured by Medismith Pharma Lab, an Indian pharmaceutical company established in 1992. Formulated according to Indian Pharmacopoeia (IP) standards, the product primarily contains isopropyl alcohol as its active antimicrobial agent. Its mechanism of action involves the denaturation of microbial proteins and the disruption of lipid bilayers, providing broad-spectrum efficacy against bacteria and fungi on the skin's surface. It is indicated for skin disinfection prior to invasive procedures, such as injections or minor surgery, and for general surface antisepsis. The product is intended for external use only and is part of Medismith's portfolio of over-the-counter topical pharmaceutical preparations.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Surgical Spirit IP.